Vitiligo after Diphencyprone for Alopecia Areata

المؤلفون المشاركون

Martins, João Mauricio
Gatti, Flávia Romero
Pires, Mario Cezar
Montealegre, F.

المصدر

Dermatology Research and Practice

العدد

المجلد 2010، العدد 2010 (31 ديسمبر/كانون الأول 2010)، ص ص. 1-2، 2ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2010-05-11

دولة النشر

مصر

عدد الصفحات

2

التخصصات الرئيسية

الأمراض

الملخص EN

The topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s.

Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe.

Side effects include local eczema with blistering, regional lymphadenopathy and contact urticaria.

Rare adverse effects include an erythema multiforme-like reaction, hyperpigmenttion, hypopigmentation, and vitiligo.

We report a 30-year-old, Brazilian male who developed vitiligo lesions following DPCP therapy for alopecia areata.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Pires, Mario Cezar& Martins, João Mauricio& Montealegre, F.& Gatti, Flávia Romero. 2010. Vitiligo after Diphencyprone for Alopecia Areata. Dermatology Research and Practice،Vol. 2010, no. 2010, pp.1-2.
https://search.emarefa.net/detail/BIM-451554

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Pires, Mario Cezar…[et al.]. Vitiligo after Diphencyprone for Alopecia Areata. Dermatology Research and Practice No. 2010 (2010), pp.1-2.
https://search.emarefa.net/detail/BIM-451554

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Pires, Mario Cezar& Martins, João Mauricio& Montealegre, F.& Gatti, Flávia Romero. Vitiligo after Diphencyprone for Alopecia Areata. Dermatology Research and Practice. 2010. Vol. 2010, no. 2010, pp.1-2.
https://search.emarefa.net/detail/BIM-451554

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-451554